Lethal quercetin-digoxin interaction in pigs

Life Sciences

Volumn 74, Issue 10, 2004, Pages 1191-1197

  Wang, Yao Horng ^a,b   Chao, Pei Dawn L ^a   Hsiu, Su Lan ^a   Wen, Kuo Ching ^a   Hou, Yu Chi ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Digoxin; Drug interaction; P glycoprotein; Pig; Quercetin

Indexed keywords

DIGOXIN; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG FATALITY; FLUORESCENCE POLARIZATION IMMUNOASSAY; JUGULAR VEIN; LETHALITY; MALE; NONHUMAN; STUDENT T TEST; SUDDEN DEATH; SWINE;

SUS SCROFA;

EID: 0347510572     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.06.044     Document Type: Article

References (25)

1. Bosch I., Croop J. P-glycoprotein, multidrug resistance and cancer. Biochimica et Biophysica Acta. 1288:1996;F37-F54.
2. Castro A.F., Altenberg G.A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochemical Pharmacology. 53:1997;89-93.
3. Chao P.D.L., Hsiu S.L., Hou Y.C. Flavonoids in herbs: biological fates and potential interactions with xenobiotics. Journal of Food and Drug Analysis. 10:2002;135-144.
4. Chieli E., Romiti N., Cervelli F., Tongiani R. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Science. 57:1995;1741-1751.
5. Critchfiels J.W., Welsh C.J., Phang J.M., Yeh C.G. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Biochemical Pharmacology. 48:1994;1437-1445.
6. Dantzig A.H., de Alwis D.P., Burgess M. Considerations in the design and development of transport inhibitors as adjuncts to drug therapy. Advanced Drug Delivery Reviews. 53:2003;133-150.
7. Di Pietro A., Conseil G., Perez-Victoria J.M., Dayan G., Baubichon-Cortay H., Trompier D., Steinfels E., Jault J.M., de Wet H., Maitrejean M., Comte G., Boumendjel A., Mariotte A.M., Dumontet C., McIntosh D.B., Goffeau A., Castanys S., Gamarro F., Barron D. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cellular and Molecular Life Science. 59:2002;307-322.
8. Ducharme M.P., Provenzano R., Dehoorne-Smith M., Edwards D.J. Trough concentrations of cyclosporin following administration with grapefruit juice. British Journal of Clinical Pharmacology. 36:1993;457-459.
9. Ducharme M.P., Warbasse L.H., Edwards D.J. Disposition of intravenous and oral cyclosporin after administration with grapefruit juice. Clinical Pharmacology and Therapeutics. 57:1995;485-491.
10. Harrison L.I., Gibaldi M. Pharmacokinetics of digoxin in the rat. Drug Metabolism and Disposition. 4:1976;88-93.
11. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study [published erratum appears in Arch. Intern. Med. 1995 Jun 12;155(11): 1184]. Archives of Internal Medicine. 155:1995;381-386.
12. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly study. Lancet. 342:1993;1007-1011.
13. Hsiu S.L., Hou Y.C., Wang Y.H., Tsao C.W., Su S.F., Chao P.D.L. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Science. 72:2002;227-235.
14. Knekt P., Jarvinen R., Seppanen R., Hellovaara M., Teppo L., Pukkala E., Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. American Journal of Epidemiology. 146:1997;223-230.
15. Lin J.H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Advanced Drug Delivery Reviews. 55:2003;53-81.
16. Lamson D.W., Brignall M.S. Antioxidants and cancer III: quercetin. Alternative Medicine. 5:2000;196-208. (Review).
17. Mitsunaga Y., Takanaga H., Matsuo H., Naito M., Tsuruo T., Ohtani H., Sawada Y. Effect of bioflavonoids on vincristine transport across blood-brain barrier. European Journal of Pharmacology. 95:2000;193-201.
18. Nijveldt R.J., van Nood E., van Hoorn D.E.C., Boelens P.G., van Norren K., van Leeuwen P.A.M. Flavonoids: a review of probable mechanisms of action and potential applications. American Journal of Clinical Nutrition. 74:2001;418-425. (Review).
19. Phang J.M., Poore C.M., Lopaczynska J., Yeh G.C. Flavonoid-stimulated efflux of 7, 12-dimethylbenz[a]anthracene in multidrug-resistant breast cancer cells. Cancer Research. 53:1993;5977-5981.
20. Rimm E.B., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Relation between intake of flavonoids and risk for coronarty heart disease in male health professionals. Annals of Internal Medicine. 125:1996;384-389.
21. 450 3A. Xenobiotica. 29:1999;171-185.
22. Scambia G., Ranelletti F.O., Panici P.B., De Vincenzo R., Bonanno G., Ferrandina G., Piantelli M., Bussa S., Rumi C., Cianfriglia M. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemotherapy and Pharmacology. 34:1994;459-464.
23. Shapiro A.B., Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted p-glycoprotein. Biochemical Pharmacology. 53:1997;587-596.
24. Su S.F., Huang J.D. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metabolism and Disposition. 24:1996;142-147.
25. Yeh G.C., Lopaczynska J., Poore C.M., Phang J.M. A new functional role for P-glycoprotein: Efflux pump for benzo[a]pyrene in human breast cancer MCF-7 cells. Cancer Research. 52:1992;6692-6695.